Nomogram for Predicting the Survival Outcome of Cabazitaxel Treatment in Patients With Metastatic Castration‐Resistant Prostate Cancer: A Multi‐Institutional Analysis
Our validated nomogram, which is predictive of the survival outcome after CBZ treatment in patients with mCRPC, may help in individual clinical decision-making.
Authors
- Hideto Ueki (ORCID: https://orcid.org/0000-0002-7742-4528)
- Naoto Wakita (ORCID: https://orcid.org/0009-0007-1353-7789)
- Junichiro Hirata
- Takuto Hara (ORCID: https://orcid.org/0000-0003-4524-2815)
- Tomoaki Terakawa (ORCID: https://orcid.org/0000-0002-4447-6516)
- Yasuyoshi Okamura (ORCID: https://orcid.org/0000-0002-8466-3949)
- Yoji Hyodo (ORCID: https://orcid.org/0000-0002-9553-0981)
- Kōji Chiba (ORCID: https://orcid.org/0000-0001-7600-7813)
- H. Miyake (ORCID: https://orcid.org/0000-0001-9572-5124)
- Kotaro Suzuki (ORCID: https://orcid.org/0000-0003-4589-9251)
- Jun Teishima (ORCID: https://orcid.org/0009-0004-7018-5095)
Institutions
- Kobe University (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1111/iju.70219
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52